__Not your usual cocktail...__ On Friday night, we learned that President Trump had tested positive for COVID-19. While he was hospitalized at Walter Reed National Medical Center (he was admitted Friday and left yesterday), he was treated with a high dose of an experimental antibody "cocktail" from American biotech company __[Regeneron](https://robinhood.com/stocks/REGN)__. 

- __The treatment isn't FDA-approved yet__, but it's in the final phase of human testing. Trump's doctor made a "compassionate use" request to get individual approval from the FDA.
- __Regeneron stock soared 7%__ on Monday on news of the presidential treatment, and is up 62% for the year. 

__Warp-er Speed...__ In July, Regeneron received $450M as part of Trump's "[Operation Warp Speed](https://snacks.robinhood.com/newsletters/2yiQjAPUMFj1LAGzjjtiR0/articles/5QsTxDVI2hgwiGCa3QkB6p)" to quickly develop COVID-19 vaccines and treatments — the US has invested over $10B in Warp Speed so far. If Trump recovers, that high-profile success could help fast-track approval for Regeneron's treatment. 

- __Regeneron [says](https://www.cnn.com/2020/10/05/investing/trump-regeneron/index.html) it's on track to make 300K doses__ of the treatment by the end of 2020. FDA approval could mean big business – especially now, when COVID cases are rising as colder weather drives people inside.

Treat

__This could be the ultimate Earned Media win...__ Earned media is basically free publicity (the opposite of paid media advertising). If Regeneron gets credited with *helping save the US President's life*, that's a significant unpaid win. It would be way more valuable to boosting brand perception than any ad Regeneron could buy.

Regeneron stock soars on Trump's dose — the ultimate PR opportunity

__Christmas came early for Elon...__ __[Tesla](https://robinhood.com/stocks/TSLA)__ delivered a record number of vehicles last quarter, accelerating its recovery after the pandemic slowdown. It's still (very) far from its [goal](https://snacks.robinhood.com/newsletters/4SQQIJGVDV1ZMsRwO23SPV/articles/KG8dXhyGvKBAcw3zvZLNj) of 20M vehicles/year, but the growth is impressive:

- __Tesla delivered 139K vehicles__ during the quarter ending September 30. That’s a 44% increase from the same quarter *last* year.
- __~90% of deliveries__ consisted of the $35K+ Model 3 or the $50K+ Model Y crossover. *Just 10%* of deliveries consisted of the $75K+ Model S or X.

__Sounds S3XY...__ That's Tesla Model S, 3, X, and Y (classic Elon humor). Deliveries last quarter were *dominated* by Tesla's new cheaper models, which cannibalized sales of the original luxe models. For most people, the pricier models are just too... pricey. *Especially* when they can now become Tesla owners through a cheaper (still sweet) ride.

- __Cannibalization:__ The terrifying term for when a company's new product is so attractive that it devours sales of its other products. 
- __The con:__ Companies fear cannibalization because it often steals sales from more profitable products. 
- __The pro:__ Lower-cost versions of products drive more sales volume and guard against competitive disruption (#disruptyoself).


Devour

__Tesla achieved cannibalization success...__ Last year, cannibalization was a *problem* for Tesla. In July 2019, Tesla [posted](https://snacks.robinhood.com/newsletters/3zxtMPGvxRsDKcOXjFQyhC/articles/3oavs96KNk4v8YXxGs47Y1/) record deliveries but *lost* $408M because its top-selling Model 3s sold for less than what they cost to make. Now that Tesla has reduced the cost of car batteries, it can actually *profit* on those Model 3 & Y sales — it  [posted](https://snacks.robinhood.com/newsletters/6511HaDUMXpAxjp2bEBL6w/articles/30QY0VGpvgwP9J9BKSTkLB) 4 straight quarters of profit, and is expected to report a 5th this month. 


Tesla hits a delivery record thanks to its cheaper models (it's cannibalizing itself)

__Hit 'em with the double entendre...__  __Cooler Screens__ just raised [$80M](https://techcrunch.com/2020/10/05/cooler-screens-series-c/) to bring interactive screens to cooler aisles. Basically, the idea is to turn your 7-Eleven fridge doors into digital [billboards](https://www.coolerscreens.com/demo). While it may sound like a Facebook ad stuck on a fridge, Cooler Screens has two key differentiators:

- __In-store:__ Most retail sales still come from physical stores, but there aren't actually ads *in* stores (they're all chilling on __Amazon__ or __Facebook__ #adparty).
- __IoT-enabled:__ The screen knows when your Walgreens is out of Mountain Dew, so it'll showcase Coke instead. Or it can highlight the tub of Häagen-Dazs that literally just went on sale. 

__Cooler story, bro...__ If this sounds like something out of a "Black Mirror" episode, that's because it kind of is. Cooler Screens offers merchants AI-powered inventory tracking, plus real-time pricing and sales data. 

- __*For customers*:__ According to its CEO, you could ask the screen to show you all the vegan ice cream, or to see the calories in a DiGiorno frozen pizza (579). 
- __Also:__ In addition to flashing nutritional facts, the screen lets you make digital payments on the spot. It doesn't collect your personal info, though (*thaaanks*). 


_Cooler Screen control center: "Hit her with the Mountain Dew"_

Future

__Point-of-Sale ads are powerful...__ If you're in a grocery store, you're there to buy something (RIP free samples). Cooler's ads are getting you  at the exact place/time when your purchasing intent is hottest. Cooler says that products behind digital doors sell 2X to 10X more. It's already in 50 __[Walgreens](https://robinhood.com/stocks/WBA)__, and is planning to expand to 2.5K more.

Regeneron stock soars on Trump's dose — the ultimate PR opportunity

Get Your News

Subscribe and thrive